What the research says
What the guidelines say
The American Gastroenterological Association’s 2022 clinical practice update on de-prescribing proton pump inhibitors (PPIs) advises clinicians to regularly review and document why a PPI is being taken. People without a definite chronic indication should be considered for a trial of stopping, and those on twice-daily dosing may be considered for a step-down to once daily.
The ACG GORD guideline similarly suggests that people whose symptoms respond to a PPI should attempt to reduce to the lowest effective dose, including on-demand use where appropriate. A Cochrane systematic review found that on-demand use can reduce pill burden in suitable patients, although symptoms return in some.[1][2][3]
Who should NOT reduce without specialist advice
Guidelines are clear that some people need ongoing acid suppression — for example those with severe erosive oesophagitis, Barrett’s oesophagus, peptic stricture, a history of bleeding ulcers, or who take medications that raise bleeding risk. Decisions about medication belong with the prescribing doctor.
The AGA also notes that concern about possible side effects alone is not a reason to stop a medication that is clearly needed; the decision should be based on whether there is an ongoing indication.[1][4]
Why symptoms can flare when stepping down
In a randomised trial, healthy volunteers with no prior reflux who took a PPI for eight weeks were significantly more likely than placebo recipients to develop heartburn and acid-related symptoms after stopping. This “rebound acid hypersecretion” is usually temporary, and guidelines recommend warning patients about it. It is one reason reductions are best planned gradually with a doctor.[5][1]
Where dietary management fits
Lifestyle and dietary measures, including weight management, meal timing and avoiding individual triggers, are part of guideline-based GORD care. Research linking gut fermentation to reflux events, and studies such as the diet-based LPR comparison by Zalvan and colleagues, support diet as a meaningful part of the plan.
In practical terms, reducing the dietary drivers of reflux before and during a doctor-supervised step-down may make the process more comfortable and sustainable.[2][6][7][8]
Douglas’s clinical observations
Practice experience from 65,000+ consultations since 1990, not research findings. Individual results vary.
Douglas is a Clinical Nutritionist, not a medical practitioner, and never advises patients to stop or change prescribed medication. What he does is help patients address the dietary and gut-health factors in their reflux, so that when they and their GP review medication, they are in the best possible position.
Over more than three decades he has seen many patients, working with their own doctors, move to a lower dose, to as-needed use, or, where their doctor agreed it was appropriate, off medication altogether. Others need to stay on medication for sound medical reasons. Both outcomes are respected.
In his experience, the patients who find the step-down smoothest are those whose fermentation triggers and meal patterns have already been addressed, so any temporary rebound is milder and easier to ride out. He encourages patients to keep a symptom diary during any doctor-approved change to share with their GP.
Key takeaways
- Guidelines support regular review and lowest-effective-dose use of PPIs, under medical supervision.
- Some conditions require ongoing medication; your doctor decides.
- Temporary rebound symptoms are common when stopping and are best planned for.
- Addressing dietary and gut drivers can support a doctor-led plan.
Educational information only. Douglas is a Clinical Nutritionist and does not diagnose medical conditions or advise on prescribed medication. Never stop or change medication without your doctor. Seek prompt medical care for difficulty swallowing, weight loss, vomiting, bleeding or chest pain (call 000 in an emergency). Red-flag symptoms
References
- 1.Targownik LE, Fisher DA, Saini SD. AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review. Gastroenterology. 2022;162(4):1334–42. (Clinical guideline) View source
- 2.Katz PO, Dunbar KB, Schnoll-Sussman FH, Greer KB, Yadlapati R, Spechler SJ. ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. Am J Gastroenterol. 2022;117(1):27–56. (Clinical guideline) View source
- 3.Boghossian TA, Rashid FJ, Thompson W, Welch V, Moayyedi P, Rojas-Fernandez C, Pottie K, Farrell B. Deprescribing versus continuation of chronic proton pump inhibitor use in adults. Cochrane Database Syst Rev. 2017;3:CD011969. (Systematic review) View source
- 4.Freedberg DE, Kim LS, Yang YX. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association. Gastroenterology. 2017;152(4):706–15. (Review) View source
- 5.Reimer C, Søndergaard B, Hilsted L, Bytzer P. Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy. Gastroenterology. 2009;137(1):80–7. (Clinical trial) View source
- 6.Ness-Jensen E, Hveem K, El-Serag H, Lagergren J. Lifestyle Intervention in Gastroesophageal Reflux Disease. Clin Gastroenterol Hepatol. 2016;14(2):175–82. (Systematic review) View source
- 7.Piche T, des Varannes SB, Sacher-Huvelin S, Holst JJ, Cuber JC, Galmiche JP. Colonic fermentation influences lower esophageal sphincter function in gastroesophageal reflux disease. Gastroenterology. 2003;124(4):894–902. (Clinical trial) View source
- 8.Zalvan CH, Hu S, Greenberg B, Geliebter J. A Comparison of Alkaline Water and Mediterranean Diet vs Proton Pump Inhibition for Treatment of Laryngopharyngeal Reflux. JAMA Otolaryngol Head Neck Surg. 2017;143(10):1023–9. (Observational study) View source
Written by
Douglas Mizzi, Clinical Nutritionist
ATMS member #8079 · In practice since 1990 · 65,000+ consultations
Douglas specialises in diet, fermentation, gut health and gut recovery. He is a nutritionist, not a medical practitioner: he does not diagnose medical conditions or prescribe or change medication. Clinical observations in these articles reflect his practice experience and are presented separately from the published research. About Douglas